Relative value assessment: characterizing the benefit of oncology therapies through diverse survival metrics from a US perspective

OBJECTIVES: The introduction of innovative, high-cost oncology treatments, coupled with mounting budgetary pressures, necessitates value trade-offs across cancer types. Defining value is critical to informing decision-making. A cost-value analysis tool was used to assess relative clinical value from...

Descripción completa

Detalles Bibliográficos
Autores principales: Macaulay, Richard, Ahuja, Amit, Ademisoye, Ebenezer, Juarez-Garcia, Ariadna, Shaw, James W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430994/
https://www.ncbi.nlm.nih.gov/pubmed/30936729
http://dx.doi.org/10.2147/CEOR.S177343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430994/
https://www.ncbi.nlm.nih.gov/pubmed/30936729
http://dx.doi.org/10.2147/CEOR.S177343

Ejemplares similares